However, a recent study using a B16 mouse melanoma model demonstrated that neither Ccr2 nor Ccr5 deficiency affect tumor infiltration of adoptively transferred CD8+ T cells, despite the fact that the tumor expresses high levels of CCL2 and CCL5 (ligands for CCR2 and CCR5, respectively). The gene discussed is CCR5; the disease is neoplasm.